首页 > 市场调查报告书 > 製药

药物开发

市场调查报告书

商品编码

1747275

药物研发平台市场：按药物类型、技术、治疗领域、应用、最终用户和地区划分

Drug Discovery Platforms Market, By Drug Type, By Technology, By Therapeutic Area, By Application, By End User, By Geography

出版日期: 2025年05月08日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球药物研发平台市场规模估计为 2.113 亿美元，预计到 2032 年将达到 5.129 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 13.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	2.113亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	13.50%	2032年价值预测	5.129亿美元

近年来，全球药物发现平台市场见证了显着增长，这得益于对新型疗法的需求不断增长以及对更高效的药物发现流程的需求。药物发现平台利用高通量筛检、基因组学、蛋白质组学和计算工具等先进技术，在识别和开发候选药物方面发挥着至关重要的作用。这些平台使研究人员能够简化药物发现流程、降低成本并缩短从初步筛检到临床试验的时间。市场包括各种类型的平台，如生化检测、基于细胞的检测、In Silico模拟和基于片段的药物发现。慢性病盛行率的不断上升、个人化医疗的兴起以及製药公司和学术机构之间合作的日益增多，进一步推动了药物发现平台的采用。

市场动态：

全球药物发现平台市场受到多种因素驱动，包括慢性病盛行率上升、个人化医疗需求成长以及对更有效率的药物发现流程的需求。癌症、心血管疾病和神经系统疾病盛行率上升导致对新型治疗药物的需求庞大，从而推动了药物发现平台市场的成长。此外，向个人化医疗的转变需要开发标靶治疗，而标靶疗法严重依赖药物发现平台来识别特定的分子标靶并优化候选药物。然而，药物发现和上市的高成本以及药物核准所需的严格监管要求制约了市场的成长。此外，熟练专业人员的短缺和整合各种技术的复杂性也对市场成长构成了挑战。儘管存在这些市场限制因素，但市场提供了巨大的商机，包括在药物发现中越来越多地采用人工智慧和机器学习、越来越关注罕见疾病以及製药公司和技术提供商之间在开发创新药物发现解决方案方面的潜在合作。

本研究的主要特点

本报告对全球药物发现平台市场进行了详细分析，并给出了预测期（2025-2032）的市场规模（百万美元）和年复合成长率（CAGR%），假设 2024 年为基准年。
它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了全球药物发现平台市场的主要企业概况。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球药物发现平台市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员将透过用于分析全球药物发现平台市场的各种策略矩阵更轻鬆地做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 211.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	13.50%	2032 Value Projection:	USD 512.9 Mn

The global drug discovery platforms market has witnessed significant growth in recent years, driven by the increasing demand for novel therapeutics and the need for more efficient drug discovery processes. Drug discovery platforms play a crucial role in the identification and development of new drug candidates, utilizing advanced technologies such as high-throughput screening, genomics, proteomics, and computational tools. These platforms enable researchers to streamline the drug discovery process, reduce costs, and accelerate the timeline from initial screening to clinical trials. The market encompasses various types of platforms, including biochemical assays, cell-based assays, in silico modeling, and fragment-based drug discovery. The adoption of drug discovery platforms has been further fueled by the growing prevalence of chronic diseases, the emergence of personalized medicine, and the increasing collaboration between pharmaceutical companies and academic institutions.

Market Dynamics:

The global drug discovery platforms market is driven by several factors, including the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the need for more efficient drug discovery processes. The rising prevalence of cancer, cardiovascular diseases, and neurological disorders has created a significant demand for novel therapeutics, propelling the growth of the drug discovery platforms market. Additionally, the shift towards personalized medicine has necessitated the development of targeted therapies, which rely heavily on drug discovery platforms for identifying specific molecular targets and optimizing drug candidates. However, the market growth is restrained by the high cost associated with drug discovery and development, as well as the stringent regulatory requirements for drug approval. Furthermore, the lack of skilled professionals and the complexity of integrating various technologies pose challenges to market growth. Despite these restraints, the market presents significant opportunities, such as the increasing adoption of artificial intelligence and machine learning in drug discovery, the growing focus on rare diseases, and the potential for collaborations between pharmaceutical companies and technology providers to develop innovative drug discovery solutions.

Key Features of the Study:

This report provides in-depth analysis of the global drug discovery platforms market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global drug discovery platforms market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, PerkinElmer, Merck KGaA, Roche Holding AG, QIAGEN, Bruker Corporation, Bio-Rad Laboratories, Illumina, Charles River Laboratories, Evotec, WuXi AppTec, Schrodinger, and Abcam
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug discovery platforms market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug discovery platforms market

Market Segmentation

Drug Type Insights (Revenue, USD Mn, 2020 - 2032)
- Small Molecule
- Large Molecule
Technology Insights (Revenue, USD Mn, 2020 - 2032)
- Genomics
- Proteomics
- Cell-Based Assays
- High-Throughput Screening (HTS)
- Bioinformatics
- Next-Generation Sequencing (NGS)
- Mass Spectrometry
- Imaging Technologies
- Microfluidics
- Artificial Intelligence (AI) & Machine Learning (ML)
Therapeutic Area Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Neurology
- Infectious And Immune System Diseases
- Digestive System Diseases
- Cardiovascular Diseases
- Diabetes
- Respiratory Disease
Application Insights (Revenue, USD Mn, 2020 - 2032)
- Target Identification
- Target Validation
- Lead Discovery
- Lead Optimization
- Preclinical Testing
- Others (Clinical Trials, etc.)
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Biopharmaceutical Companies
- Academic and Research Institutes
- CROs/CDMOs
- Others
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Thermo Fisher Scientific
- Agilent Technologies
- Danaher Corporation
- PerkinElmer
- Merck KGaA
- Roche Holding AG
- QIAGEN
- Bruker Corporation
- Bio-Rad Laboratories
- Illumina
- Charles River Laboratories
- Evotec
- WuXi AppTec
- Schrodinger
- Abcam

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Drug Discovery Platforms Market, By Drug Type
- Global Drug Discovery Platforms Market, By Technology
- Global Drug Discovery Platforms Market, By Therapeutic Area
- Global Drug Discovery Platforms Market, By Application
- Global Drug Discovery Platforms Market, By End User
- Global Drug Discovery Platforms Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Drug Discovery Platforms Market, By Drug Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Small Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Large Molecule
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Drug Discovery Platforms Market, By Technology, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Genomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Proteomics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cell-Based Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
High-Throughput Screening (HTS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Bioinformatics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Next-Generation Sequencing (NGS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Imaging Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Microfluidics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Artificial Intelligence (AI) & Machine Learning (ML)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Drug Discovery Platforms Market, By Therapeutic Area, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Infectious And Immune System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Digestive System Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Drug Discovery Platforms Market, By Application, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Target Identification
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Target Validation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Lead Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Lead Optimization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Preclinical Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others (Clinical Trials, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Drug Discovery Platforms Market, By End User, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
CROs/CDMOs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Drug Discovery Platforms Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Area, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agilent Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
PerkinElmer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
QIAGEN
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bruker Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Illumina
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Schrodinger
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abcam
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

药物研发平台市场：按药物类型、技术、治疗领域、应用、最终用户和地区划分